Matthew E. Korenberg, President & Chief Operating at LIGAND PHARMACEUTICALS INC (LGND), sold 34,676 shares at $85.08 ($2.9M) on 2024-05-14, disclosed to the SEC on 2024-05-15.
Open-market sale of $2.9M LGND by President & Chief Operating. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.54 | 3,440 | $291K | 9.9% |
| 2 | $84.54 | 3,440 | $291K | 9.9% |
| 3 | $85.08 | 13,638 | $1.2M | 39.4% |
| 4 | $85.08 | 13,638 | $1.2M | 39.4% |
| 5 | $85.68 | 520 | $45K | 1.5% |
| Total | $84.98 avg | 34,676 |
| $2.9M |
| 100% |
| Filing → |
| LGND | SELL | 2024-08-13 | $3.6M | — | Filing → |
| LGND | BUY | 2019-09-03 | $43K | — | Filing → |
| LGND | SELL | 2018-08-29 | $9.4M | — | Filing → |